Health Canada drug identification number

DIN 02530635 — FULVESTRANT INJECTABLE 250 MG

FULVESTRANT INJECTABLE is a solution of Fulvestrant marketed by JAMP PHARMA CORPORATION. The full Fulvestrant monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02530635
Brand name
FULVESTRANT INJECTABLE
Active ingredient
Fulvestrant
Strength
250 MG
Dosage form
SOLUTION
Route
INTRAMUSCULAR
Manufacturer
JAMP PHARMA CORPORATION
Health Canada status
MARKETED
Drug class
Nonagonist estrogen receptor antagonist

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Fulvestrant products

DINBrandStrengthFormManufacturerStatus
02248624 FASLODEX 250 MG SOLUTION ASTRAZENECA CANADA INC MARKETED
02483610 FULVESTRANT INJECTION 250 MG SOLUTION SANDOZ CANADA INCORPORATED MARKETED
02536293 FULVESTRANT INJECTION 250 MG SOLUTION FORMATIVE PHARMA INC. MARKETED
02558971 FULVESTRANT INJECTION 250 MG SOLUTION STERIMAX INC MARKETED
02460130 TEVA-FULVESTRANT INJECTION 250 MG SOLUTION TEVA CANADA LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.